Mirjam Leeder,Katharina Leucht,Maria Marx et al.
Mirjam Leeder et al.
Background: Non-muscle-invasive bladder cancer (NMIBC) is characterized by high rates of recurrence and progression, particularly in high-risk disease. Despite transurethral resection and adjuvant intravesical Bacillus Ca...
[Diagnosis and treatment of urothelial carcinoma of the bladder with divergent histology] [0.03%]
膀胱尿路上皮癌伴异源组织分化的诊断和治疗
Nadine Therese Gaisa,Henning Reis,Axel Heidenreich
Nadine Therese Gaisa
The diagnosis "urothelial carcinoma with divergent histology (UC-DH)" subsumes urothelial carcinomas that have additional histological features beyond conventional UC (not-otherwise specified, NOS). These include UCs with additional squamou...
[Neoadjuvant therapy and complete response of muscle-invasive bladder cancer: may the urinary bladder be preserved?] [0.03%]
肌层浸润性膀胱癌的新辅助治疗和完全缓解后能否保留膀胱？
Christian Bolenz,Friedemann Zengerling,Hubert Kübler et al.
Christian Bolenz et al.
Radical cystectomy (RC) with pelvic lymphadenectomy followed by urinary diversion is the standard treatment for muscle-invasive bladder cancer (MIBC). Perioperative systemic therapy can improve the oncological outcome of RC. Despite the use...
Désirée Louise Dräger,Chris Protzel
Désirée Louise Dräger
Penile cancer is a rare but relevant tumor entity. Due to the low case numbers in individual hospitals deviations from treatment standards and delayed treatment repeatedly occur. This is all the more serious as only an early and consistent ...
Jakob Kohler,Severin Rodler,Julian Andersson et al.
Jakob Kohler et al.
Background: Imaging guides the staging of urothelial carcinoma and thus plays a central role in treatment decisions. Current guidelines reflect the increasing importance of multiparametric MRI (mpMRI) of the bladder with ...
Neue Horizonte in der Uroonkologie : 16. AuF-Symposium 2025 in Innsbruck [0.03%]
泌尿肿瘤学的新视野：因斯布鲁克2025年AU-F Symposium会议
Christoph Becker
Christoph Becker
[Artificial intelligence in surgical disciplines: Clinical application, advantages, and potential-a Delphi expert consensus] [0.03%]
外科专科的手术人工智能：临床应用、优势及潜在作用——德尔菲专家共识
G Duwe,K Moench,V Kauth et al.
G Duwe et al.
Background: Artificial intelligence (AI) in surgical disciplines has the potential to support all areas of patient care, with the goal of improving treatment quality and patient safety. A group of multidisciplinary expert...
[From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma] [0.03%]
从非靶向治疗到精准肿瘤学：晚期尿路上皮癌的预测生物标志物和靶向治疗
Günter Niegisch,Stefanie Zschäbitz,Markus Eckstein et al.
Günter Niegisch et al.
For many decades, the treatment of metastatic urothelial carcinoma (mUC) was dominated by platinum-based chemotherapy. However, the introduction of immune checkpoint inhibitors in combination with modern antibody-drug conjugates (ADCs) and ...
[Report of the 31st annual meeting of the kidney transplantation working group of the German Society of Urology in Erlangen in 2025] [0.03%]
2025年德国泌尿外科协会肾脏移植工作组第31届年度会议报告
Anna Sophia Kienel,Frank Friedersdorff,Georgios Gakis et al.
Anna Sophia Kienel et al.